This company combines impressive quality with a generous valuation: UnitedHealth Group Incorporated (UNH)

In the latest session, UnitedHealth Group Incorporated (NYSE: UNH) closed at $523.09 up 1.14% from its previous closing price of $517.19. In other words, the price has increased by $+5.90 from its previous closing price. On the day, 2562030 shares were traded. UNH stock price reached its highest trading level at $524.66 during the session, while it also had its lowest trading level at $519.91.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



For a deeper understanding of UnitedHealth Group Incorporated’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.63. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.61.

Upgrades & Downgrades

On June 17, 2022, Loop Capital started tracking the stock assigning a Buy rating and target price of $575.

Bernstein Downgraded its Outperform to Mkt Perform on May 27, 2022, while the target price for the stock was maintained at $561.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 26 when ROOS THOMAS E sold 465 shares for $542.37 per share. The transaction valued at 252,201 led to the insider holds 34,786 shares of the business.

McMahon Dirk C sold 14,715 shares of UNH for $7,994,939 on Aug 18. The Pres. & COO, UHG & CEO, UHC now owns 50,108 shares after completing the transaction at $543.32 per share. On Jul 29, another insider, REX JOHN F, who serves as the EVP Chief Financial Officer of the company, sold 13,183 shares for $541.53 each. As a result, the insider received 7,138,990 and left with 141,508 shares of the company.

Valuation Measures:

As of this moment, UnitedHealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.62, and their Forward P/E ratio for the next fiscal year is 20.99. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.80. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.51 while its Price-to-Book (P/B) ratio in mrq is 6.55.

Stock Price History:

Over the past 52 weeks, UNH has reached a high of $558.10, while it has fallen to a 52-week low of $436.00. The 50-Day Moving Average of the stock is 523.65, while the 200-Day Moving Average is calculated to be 512.01.

Shares Statistics:

For the past three months, UNH has traded an average of 2.85M shares per day and 4.06M over the past ten days. A total of 935.00M shares are outstanding, with a floating share count of 929.88M. Insiders hold about 0.10% of the company’s shares, while institutions hold 89.70% stake in the company. Shares short for UNH as of Oct 13, 2022 were 4.33M with a Short Ratio of 5.16M, compared to 5.07M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.46% and a Short% of Float of 0.47%.

Dividends & Splits

According to the company, the forward annual dividend rate for UNH is 6.60, from 5.00 in the trailing year. Against a Trailing Annual Dividend Yield of 0.97%, it implies a Forward Annual Dividend Yield of 1.22%. The stock’s 5-year Average Dividend Yield is 1.35. The current Payout Ratio is 29.90% for UNH, which recently paid a dividend on Dec 12, 2022 with an ex-dividend date of Sep 08, 2022. Stock splits for the company last occurred on May 30, 2005 when the company split stock in a 2:1 ratio.

Earnings Estimates

There are 19 different market analysts currently analyzing its stock. On average, analysts expect EPS of $5.16 for the current quarter, with a high estimate of $5.3 and a low estimate of $5.05, while EPS last year was $4.48. The consensus estimate for the next quarter is $6.2, with high estimates of $6.69 and low estimates of $5.67.

Analysts are recommending an EPS of between $22.24 and $21.9 for the fiscal current year, implying an average EPS of $22.03. EPS for the following year is $24.93, with 22 analysts recommending between $25.39 and $24.5.

Revenue Estimates

A total of 16 analysts believe the company’s revenue will be $81.97B this quarter.It ranges from a high estimate of $83.05B to a low estimate of $80.75B. As of the current estimate, UnitedHealth Group Incorporated’s year-ago sales were $73.74B, an estimated increase of 11.20% from the year-ago figure. For the next quarter, 12 analysts are estimating revenue of $88.29B, an increase of 12.10% over than the figure of $11.20% in the same quarter last year. There is a high estimate of $89.53B for the next quarter, whereas the lowest estimate is $85.24B.

A total of 18 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $325.02B, while the lowest revenue estimate was $322.12B, resulting in an average revenue estimate of $323.33B. In the same quarter a year ago, actual revenue was $287.6B, up 12.40% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $352.53B in the next fiscal year. The high estimate is $360.77B and the low estimate is $343.81B. The average revenue growth estimate for next year is up 9.00% from the average revenue estimate for this year.